Compound K attenuates hyperglycemia by enhancing glucagon-like peptide-1 secretion through activating TGR5 via the remodeling of gut microbiota and bile acid metabolism
Open Access
- 31 March 2022
- journal article
- research article
- Published by Elsevier in Journal of Ginseng Research
- Vol. 46 (6) , 780-789
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Ginsenoside Rb1 and compound K improve insulin signaling and inhibit ER stress-associated NLRP3 inflammasome activation in adipose tissueJournal of Ginseng Research, 2016
- Targeting development of incretin-producing cells increases insulin secretionJournal of Clinical Investigation, 2014
- Loss of Cyp8b1 Improves Glucose Homeostasis by Increasing GLP-1Diabetes, 2014
- Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activationArchives of Pharmacal Research, 2014
- The Intestinal Crypt, A Prototype Stem Cell CompartmentCell, 2013
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR AntagonistCell Metabolism, 2013
- Commensal Bacteroides Species Induce Colitis in Host-Genotype-Specific Fashion in a Mouse Model of Inflammatory Bowel DiseaseCell Host & Microbe, 2011
- Foxa1 and Foxa2 Control the Differentiation of Goblet and Enteroendocrine L- and D-Cells in MiceGastroenterology, 2009
- Bile Acids Metabonomic Study on the CCl4- and α-Naphthylisothiocyanate-Induced Animal Models: Quantitative Analysis of 22 Bile Acids by Ultraperformance Liquid Chromatography−Mass SpectrometryChemical Research in Toxicology, 2008
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesThe Lancet, 2006